CN Patent

CN112006995A — 一种氢溴酸伏硫西汀片的制备方法

Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2020-12-01 · 5y expired

What this patent protects

本发明提供一种氢溴酸伏硫西汀片的制备方法。所述氢溴酸伏硫西汀片由底片和包衣组成。本发明在制粒过程中通过控制流化床进风温度75℃‑85℃、进风量500m 3 /h‑700m 3 /h,使得制得的颗粒松密度在0.3‑0.4g/ml、水分1.5%~3%范围内,压片制得的底片相比于对比例次品率低、片重差异小,同时解决了对比例底片早期溶出缓慢的问题,有很好的产业应用前景。

USPTO Abstract

本发明提供一种氢溴酸伏硫西汀片的制备方法。所述氢溴酸伏硫西汀片由底片和包衣组成。本发明在制粒过程中通过控制流化床进风温度75℃‑85℃、进风量500m 3 /h‑700m 3 /h,使得制得的颗粒松密度在0.3‑0.4g/ml、水分1.5%~3%范围内,压片制得的底片相比于对比例次品率低、片重差异小,同时解决了对比例底片早期溶出缓慢的问题,有很好的产业应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN112006995A
Jurisdiction
CN
Classification
Expires
2020-12-01
Drug substance claim
No
Drug product claim
No
Assignee
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.